Histopathological diagnosis and outcome of paediatric nephrotic syndrome

Journal of the College of Physicians and Surgeons Pakistan

Volumn 14, Issue 4, 2004, Pages 229-233

  Ejaz, Iftikhar ^a,b   Khan, Humayun Iqbal ^a   Javaid, Bushra Karim ^a   Rasool, Ghulam ^a   Bhatti, Mohammad Tariq ^a  

^a KING EDWARD MEDICAL UNIVERSITY   (Pakistan)

^b MAYO HOSPITAL   (Pakistan)

Author keywords

Focal segmental glumerulosclerosis; Membranoproliferative glumerulonephritis mesangiocapillary glumerulonephritis; Mesangioproliferative glumerulonephritis; Minimal changes disease; Paediatric nephrotic syndrome; Renal biopsy

Indexed keywords

ACETYLSALICYLIC ACID; ALKYLATING AGENT; COMPLEMENT COMPONENT C3; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPYRIDAMOLE; LEVAMISOLE; METHYLPREDNISOLONE; PREDNISOLONE; STEROID; GLUCOCORTICOID;

ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DRUG DOSE REGIMEN; DRUG PULSE THERAPY; DRUG RESPONSE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; FREQUENCY ANALYSIS; HEMATURIA; HISTOPATHOLOGY; HUMAN; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NEPHROTOXICITY; PAKISTAN; PATIENT SELECTION; PROLIFERATIVE GLOMERULONEPHRITIS; RELAPSE; INFANT; LIPOID NEPHROSIS; PATHOLOGY; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; GLUCOCORTICOIDS; HUMANS; INFANT; NEPHROSIS, LIPOID; NEPHROTIC SYNDROME; PREDNISOLONE;

EID: 3142663066     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Ashraf M, Ahmad N, Muhammad T. Plasma albumin concentration and hyperlipidemia in nephrotic syndrome. Prof Med J 1992; 1: 172-5.
2. Nephrotic syndrome. In: Behrman RE, Kliegman RM, Jensen HB, (edi). Nelson textbook of pediatrics. 16th ed. Philadelphia: WB Saunders; 2000; 1592-6.
3. Marri SM, Rizwan QM, Syed A, Samad N, Naeem M. Hypercholestrolemia in patients of nephrotic syndrome. Prof Med J 2000; 7: 84-6.
4. The nephrotic syndrome. In: Nash MA, Edelmann CM Jr, Bernstein J, Barnett HL, (edi). Paediatric kidney diseases. 2nd ed. Boston: Little Brown; 1992: 1247-66.
5. Haycock GB. Steroid responsive nephrotic syndrome. In: Postlethwaite RJ, (edi). Clinical paediatric nephrology. 2nd ed. Oxford: Butterworth Heinemann; 1994. 210.
6. Berns JS, Graudio KM, Krassner LS, Anderson FP, Durante D, McDonald BM, et al. Steroid responsive nephrotic syndrome of childhood: a long-term study of clinical course, histopathology, efficiency of cyclophosphamide therapy and effects on growth. Am J Kidney Dis 1987; 9: 108-14.
7. Adu D, Amin Addo Y, Foll AK, Blankson JM, Annobil SH, Reindorf CA, et al. The nephrotic syndrome in Ghana: clinical and pathological aspects. J Med 1981; 50: 297-306.
8. Pukerson ML, Joist JH, Greenberg JM, Kay D, Hoffsten PE, Klahr S. Inhibition by anticoagulant drugs in progressive hypertension and uremia associated with renal infarction in rats. Thrombs Res 1982; 26: 277-40.
9. Hendrickse RG, Glasgow EF, Adenyi A, Edington GM, Glasgow EF, White RH, Hollba V. Quartan malaria nephrotic syndrome. Collaborative clinicopathologinc study in Nigerian children. Lancet 1972: 1 1143-9.
10. Barnett HL, Schoneman, Bernstein J. The nephrotic syndrome. In: Edelmann CM, (edi). Pediatric kidney disease. Bostan: Little Brown 1978: 697.
11. Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis: a report of the international study of kidney disease in children. Kidney Int 1978; 13: 159-65.
12. Schnaper HW, Robsan AM. Nephrotic syndrome: minimal change disease, focal glumerulosclerosis, and related disorders. In: Schrier RW, Gottschalk CW, (edi). Diseases of the kidney. Vol.II. 5th ed. Boston: Little Brown 1993: 1745.
13. Arbeitsgemein schaft fur pediatrisch nephrologic. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Lancet 1988; 1: 38.
14. Mendoza SA, Reznik VM, Griswold WR, Krensky AM, Yorgin PD, June BM. Treatment of steroid resistant focal segmental glomerulosclerosis with pulse methylprednisolone and alkylating agents. Pediatr Nephrol 1990; 4: 303-7.
15. Coggin CH. Membranous nephropathy. In: Schrier RW, Gottschalk CW, (edi). Diseases of the kidney. Vol.II. 5th ed. Boston: Little Brown; 1993: 1785.
16. Donadio JV Jr. Membranoproliferative glomerulonephritis. In: Schrier RW, Gottschalk CW (edi). Diseases of the kidney. Vol.II. 5th ed. Boston: Little Brown; 1993: 1825.
17. Hass M, Meehan SM, Karrison TG, Spargo BH. Changing etiologies of unexplained adults nephrotic syndrome: a comparison of renal biopsy finding. 1976-1979, 1995-1997. Am J Kidney Dis 1997; 30: 621-31.
18. Kari JA. Changing trends of histopathology in childhood nephrotic syndrome in Western Saudi Arabia. Saudi Med J 2002; 23 317-21.
19. Inguli E, Tejani A. Racial difference in the incidence and renal outcome of idiopathic FSG, in children. Pediatr Nephrol 1991; 5: 393-7.
20. Gulati S, Anjay P, Sharma MD, Sharma RK, Gupta A. Changing trends of histopathology in childhood nephrotic syndrome. Am J Kidney Dis 1999; 34: 576-82.
21. Border WA. Distinguishing minimal change disease from mesangeal disorder. Kidney Int 1988; 34: 419-34.
22. Ahmad H, Tajani A. Predictive value of repeat renal biopsies in children with nephrotic syndrome. Nephron 2000; 84: 342-64.
23. Webb WJ, Lewis MA, Iqbal J, Smart PJ, Lendon M, Postlchwaite RJ. Childhood steroid sensitive nephrotic syndrome: does the histology matter? Am J Kidney Dis 1996; 27: 484-8.
24. McDonald J, Murphy AV, Arneil GC. Long-term assessment of cyclophosphamide therapy for nephrosis in children. Lancet 1974; 2: 980-2.
25. Lentz RD, Bergstein J, Steffes MW, Brown DR, Prem K, Michael AF, et al. Postpubertal evaluation of gonadal function following cyclophosphamide therapy before and during puberty. J Pediatr 1977; 91: 385-94.
26. Kitano Y, Yoschikawa N, Tanaka R, Nakamuna H, Ninomiya M, Ito H. Cyclosporine treatment in children with steroid dependent nephrotic syndrome. Pediatr Nephrol 1990; 4: 474-7.
27. Edelmann CM Jr. Long-term low dose prednisolone ameliorate the course of membranoproliferative glumerulonephritis (MPGN): a report of the international study of kidney diseases in children. Pediatr Res 1987; 21: 474-6.
28. International study of kidney disease in children: alternate day steroid therapy in membranoproliferative glomerulonephritis: a randomized controlled clinical trial. Kidney Int 1982; 21: 150-7.
29. West CD, McEnery PT, McAdams AJ. Experience with alternate day prednisone in the management of forty-five children with membranoproliferative GN (MPGN). In: Murakami K, Kitagawa T, Yabuta K, Sakai T, (edi). Recent advances in pediatric nephrology. Amsterdam: Excerpta Medica; 1987; 81-7.
30. Sivbley RK, Kimy. Dense intramembranous deposit disease. Kidney Int 1985; 25: 660-70.
31. Ramirez F, Brouhard DH, Travis LV, Ellisen. Idiopathic membranous nephropathy in children. J Pediatr 1982; 101: 677-81.
32. Gulati S, Sharma AP, Sharma RK, Gupta A, Gupta RK. Do current recommendations for kidney biopsy in nephrotic syndrome need modification. Pediatr Nephrol 2002: 17: 404-8.
33. Broyer M, Meyrier A, Naudet P, Habib R. Minimal changes and focal glomerular sclerosis. In: Davison AM, Cameron JS, Grunfeld JP. Kerr DNS, Ritz E, Winerals CG, (edi). Oxford textbook of clinical nephrology. 2nd ed. Oxford: Oxford University Press; 1998; 493-535.
34. Idezok Nowicka E, Ksiazek J, Krynsek J, Wyszynska T. Verification of indication of kidney biopsy in children with steroid dependent nephrotic syndrome. Pediatr Nephrol 1996; 71: 679-83.